VIMIZIM
Live / Registered — Registered and renewed (as of 27 Jul 2024)
What this means for you
Registered since 27 May 2014. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 27 May 2024).
Record
- Serial number
- 85599526
- Registration number
- 4538367
- Mark type
- Stylized text
- Filed
- 17 Apr 2012
- Published for opposition
- 11 Sept 2012
- Registered
- 27 May 2014
- Next maintenance due
- 27 May 2024
- Attorney of record
- Richard M. LaBarge
Goods and services
- Class 005 — Pharmaceuticals: pharmaceutical preparations for the treatment of genetic diseases and disorders; pharmaceutical preparations for use in enzyme therapy
Owner
- Biomarin Pharmaceutical, Inc., Novato, CA, US
- Biomarin Pharmaceutical, Inc., Novato, CA, US
- Biomarin Pharmaceutical, Inc., Novato, CA, US
Prosecution history
- 27 Jul 2024 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 27 Jul 2024 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 27 Jul 2024 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 27 Jul 2024 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 06 May 2024 — TEAS SECTION 8 & 9 RECEIVED
- 27 May 2023 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 01 Apr 2020 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 01 Apr 2020 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 01 Apr 2020 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 05 Feb 2020 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 05 Feb 2020 — TEAS SECTION 8 & 15 RECEIVED
- 27 May 2019 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 27 May 2014 — REGISTERED-PRINCIPAL REGISTER
- 24 Apr 2014 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 10 Apr 2014 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED